PyInvesting

Market research

TMO Thermo Fisher Scientific Inc

NYSE USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market cap
233B
P/E ratio
33.9
Analyst target
631.4231
Dividend yield
0.3%
Beta
0.85

Community

Investor discussion

9 comments

Admin profile picture
Admin

5 years, 4 months ago

Thermo Fisher Scientific Inc is currently in a long term uptrend where the price is trading 9.4% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.7.

Thermo Fisher Scientific Inc's total revenue rose by 54.5% to $11B since the same quarter in the previous year.

Its net income has increased by 149.3% to $2B since the same quarter in the previous year.

Finally, its free cash flow grew by 69.5% to $3B since the same quarter in the previous year.

Based on the above factors, Thermo Fisher Scientific Inc gets an overall score of 5/5.

Chris profile picture
Chris

5 years, 7 months ago

@spw168 $TMO is the only other FDA approved company for the new strain. This news dropped Friday which is why this stream is blowing up
ankit profile picture
ankit

5 years, 7 months ago

$TMO good run. I sold my calls yesterday with profit
M C profile picture
M C

5 years, 7 months ago

@Lookingdown Nice article confirming once again that Inovio is not a "one-trick" pony. The Covid-19 pandemic and INO-4800's candidacy with CDMO's like: Thermofisher $TMO (Int'l); Kaneka Eurogentec (Europe) Ology Bioservices (US); Richter-Helm BioLogics (US); Advaccine (China) will help validate Inovio's DNA medicine platform. Then INO-5401 and INO-9012 will bring in the thick slices of profit for cancer treatment into Inovio's coffers along with the VGX-3100 REVEAL P3 readout in Q1 2021. Let the pre-orders from big funders like CoVax, CEPI, US. Dept. of Defense for INO-4800 and Cellectra Devices make it rain!
Ramp profile picture
Ramp

5 years, 7 months ago

$OPGN @danboyle @Doctor1960 @Junkie1 @John62 Yep, Jones is in bed with $QGEN . Could also be $MRK or $TMO. Any way you look at it, we are sitting on a gold mine.
Cvrdcall1 profile picture
Cvrdcall1

5 years, 7 months ago

$TMO big consolidation here for a while. Coiled
Lauren profile picture
Lauren

5 years, 8 months ago

$LXXGF I own a few of the diagnostics companies such as $IDXX, $ZTS, $TMO, and $TTOO. I follow Chris Camillo's social arbitrage style investing and I noticed LexaGene starting to get mentioned a lot on the Twitter feeds of a few of the biotech accounts I follow. I looked into it and am (pleasantly) surprised the public doesn't really know about this company. I like the potential in the open access and vet space; am looking at the FDA EUA for Covid-19 as a bonus. I initiated a position in this and will follow closely. This company fits the social arb investing strategy very well.
Harry Popowich profile picture
Harry Popowich

5 years, 8 months ago

$TMO Anyone else like the March 500 call options?
Biotech Is Boomin profile picture
Biotech Is Boomin

5 years, 8 months ago

$OPGN Who is gonna win the bidding war for Ares global distribution? Will it be $QGEN or $TMO ? Both companies could also easily buy out OpGen.